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Eyelid tumors are a common disorder encountered by
oculoplastic surgeons. A certain proportion are malignant,
with the potential to threaten a patient’s life [1,2].
Unfortunately, malignant tumors can be presumed to be
benign. Some surgically removed tumors may not be sent
for pathologic examination, especially in private clinics. In
this study, we analyzed the frequency of malignancy in
normal eyelid tumor surgery.
Eyelid tumors such as actinic keratosis, basal cell
carcinoma, and squamous cell carcinoma, especially those
that are malignant, have been reported to bear a relationship
to sunlight exposure [3–6]. Southern Taiwan is located in a
subtropical area where there is exposure to strong sunlight.
In this study, we analyzed the frequencies of different
eyelid tumors in the area.
Large and malignant eyelid tumors usually require
wide resection. The large defect requires eyelid
reconstruction, including different methods of flapping
and grafting to restore the normal function of the eyelid and
to avoid complications such as lagophthalmos, ectropion,
and subsequent keratopathy. In this study, we analyzed the
surgical results of tumor resection.
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This retrospective case analysis investigated the epidemiology of eyelid tumors in a subtropical area. The
study assessed the proportion of all eyelid tumors that were malignancies, the accuracy of diagnosis, and
surgical results. We retrospectively collected all cases of eyelid tumors in the Department of Ophthalmology,
Kaohsiung Medical University, Taiwan, between January 1994 and December 1998. Among the 144 cases
collected, about half of the tumors were located in the upper eyelids and the other half in the lower eyelids.
Nearly 50% of cases underwent tumor resection with eyelid reconstruction. When followed up to April
1999, 97% of patients were satisfied with the surgical results. There were 18 cases (12.5%) of malignant
tumors, including 14 basal cell carcinomas, three sebaceous carcinomas, and one squamous cell carcinoma.
Before surgery, two malignancies were presumed to be benign tumors while another two were thought
to be different malignant tumors. The benign tumors included 38 nevi, 15 squamous papillomas, 13 cysts,
11 verrucae, 10 seborrheic keratoses, four hemangiomas, and others. All tumors that were thought to be
malignancies were treated using complete resection with margin monitoring by frozen section. At the
end of follow-up, no recurrence was noted. More than 10% of cases of eyelid tumors in this subtropical
teaching hospital were malignant. All surgeons should be alert to this phenomenon when they operate
on an eyelid tumor. The best policy is to send all specimens for pathologic examination.
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PATIENTS AND METHODS
We retrospectively collected consecutive cases of patients
with eyelid tumors who underwent surgery between
January 1994 and December 1998 in the Department of
Ophthalmology, Kaohsiung Medical University, Taiwan.
Demographic data, tumor location, surgical procedures
and their results, and histopathologic findings were
reviewed and analyzed.
RESULTS
The 144 collected cases included 47 male and 97 female
patients whose ages ranged from 5 to 92 years (mean,
48.3 years). Of the tumors, 71 (49.3%) were located in
the upper eyelids and 71 (49.3%) in the lower eyelids. In
two cases, tumors were located in both the upper and
lower eyelids.
Of these 144 cases, 71 underwent simple excision, 42
underwent excision with skin-muscular flaps, 18 were
treated with a pentagonal resection of the full thickness of
the eyelid with or without cantholysis, and six cases
underwent tumor resection with Tenzel semicircular flaps
and canthoplasties. Four patients underwent resection and
the Hughes procedure, one underwent resection and Culter-
Beard procedure, one underwent excision with skin graft,
and one underwent excision with a conjunctival graft.
Excluding 16 cases without complete follow-up, the results
of wound healing were uneventful in 123 cases (96.1%).
Five cases did not have successful wound healing: two
cases had wound gaps, two had lid notches, and one had
preseptal cellulites. Results were cosmetically satisfactory
in 96.9% of patients.
There were 18 cases (12.5%) of histologically malignant
tumors, including 14 basal cell carcinomas, three sebaceous
carcinomas, and one squamous cell carcinoma. Benign
tumors included nevi, squamous papillomas, cysts, verrucae,
seborrheic keratoses, granulomatous inflammation,
hemangiomas, and angiokeratomas (Table 1). Among the
38 nevi, 28 were intradermal, nine were compound, and one
was a blue nevus. Of the 13 cysts, eight were epidermoid,
two were dermoid, two were epidermal inclusion cysts,
and one was a sebaceous cyst. Resected specimens from 15
cases were not sent for pathologic examination.
All tumors that were thought to be basal cell carcinoma,
squamous cell carcinoma, or sebaceous carcinoma
underwent complete resection with margins monitored
using frozen section. At the end of follow-up (April 1999),
no recurrence was noted. Further analysis showed that
most malignant tumors occurred in females (74%) and in
the lower eyelids (79%) (Table 2). All three cases of sebaceous
carcinomas occurred in the upper eyelids. All but one of the
basal cell carcinomas occurred in the lower eyelids. The one
case of basal cell carcinoma located in the upper eyelid was
preoperatively misdiagnosed as a sebaceous carcinoma.
Among other malignant tumors, three were misdiagnosed
before surgery. The first case was a pigmented basal cell
carcinoma that was misdiagnosed as a nevus; this patient
later underwent secondary excision at the previous surgical
site using resection with margins monitored by frozen
section. The second case was a basal cell carcinoma that was
misdiagnosed as a verruca. However, pathology showed
that the resection margins were free of tumor cells. The
patient was followed for 49 months without recurrence.
The last case was a squamous cell carcinoma that was
misdiagnosed as an ulcerative basal cell carcinoma.
However, frozen section allowed the misdiagnosis to be
immediately corrected and the resection margins in the
primary operation were free of tumor cells.
Table 1. Pathology of eyelid tumors
Malignant tumors
Basal cell carcinoma 14
Sebaceous carcinoma 3
Squamous cell carcinoma 1
Benign tumors
Nevi 38
Squamous papilloma 15
Cyst 13
Verruca 11
Seborrheic keratosis 10
Granulomatous inflammation 6
Hemangioma 4
Angiokeratoma 3
Lipomatous infiltration 2
Keratoacanthoma 1
Cylindroma 1
Pleomorphic adenoma 1
Chondroid syringoma 1
Apocrine hidrocystoma 1
Pilomatrixoma 1
Neurofibroma 1
Fibrous histiocytoma 1
Arteriovenous hemangioma 1
Unknown 15
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Table 2. Demographic data and clinical features of malignant eyelid tumors
Case Age (yr)/ Location Preliminary Final pathologic diagnosis Surgical procedures Follow-up
Sex diagnosis (mo)
1  48/F Lower lat. BCC BCC (ulcerative) Excision + Tenzel flap 15
2 64/F Lower BCC BCC (ulcerative) Excision + advanced flap 6
3 55/F Lower Nevus BCC (pigmented) Excision + advanced flap 3
4  67/M Lower BCC BCC (pigmented) Excision + Hughes procedure 4
5  59/F Lower BCC BCC (pigmented) Excision + advanced flap 11
6 71/F Lower BCC BCC (morpheaform) Excision + Hughes procedure 60
7 54/M Lower BCC BCC (ulcerative) Excision + Tenzel flap 44
8 54/F Lower BCC BCC (pigmented) Excision + penta. 14
9 76/F Lower BCC BCC (ulcerative) Excision + rotational flap 29
10 45/M Lower BCC BCC (pigmented) Excision + skin flap 58
11 52/F Lower BCC BCC (ulcerative) Excision + reconstruction 55
12 57/M Upper Seb. C. BCC (ulcerative) Excision + reversed Hughes 22
13 57/F Lower Verruca BCC Excision 49
14 73/F Lower BCC BCC Excision + Tenzel flap 12
15 67/F Upper Seb. C Seb. C. Excision + reconstruction 4
16 89/F Upper Seb. C. Seb. C. Excision + reversed Hughes 1
17 52/F Upper Seb. C. Seb. C. Excision + Culter-Beard 15
18 61/M Lower BCC SCC Excision + Tenzel flap 3
F = female; M = male; lat. = lateral; BCC = basal cell carcinoma; penta. = pentagonal resection; Seb. C. = sebaceous carcinoma; SCC = squamous
cell carcinoma.
Figure 1. Morpheaform basal cell carcinoma. (A) A 71-year-old female
patient presented with a diffuse, hard tumor in the right lower eyelid for
several months; (B) a large defect was noted after complete resection;
(C) the Hughes procedure was performed; (D) postoperative appearance.
Figure 2. Basal cell carcinoma mimicking sebaceous gland carcinoma.
(A) A 57-year-old male patient presented with a nodular, ulcerated tumor
mass in the left upper eyelid that had been growing for several months; (B)
postoperative appearance after a reversed Hughes procedure was performed.
Case descriptions
Case 6 (Table 2, Figure 1): a 71-year-old woman presented
with a diffuse, hard tumor in the right lower eyelid for
several months. She underwent resection for morpheaform
basal cell carcinoma, with margins monitored by frozen
section. A large defect was noted after complete resection.
The Hughes procedure was performed and a good result
was achieved [7]. Pathology confirmed the clinical diagnosis.
No recurrence occurred during 5 years of follow-up. The
patient was satisfied with the cosmetic results.
Case 12 (Table 2, Figure 2): a 57-year-old man presented
with a nodular, ulcerated tumor mass in the left upper
eyelid that had been growing for months. He underwent
resection for sebaceous carcinoma, with margins monitored
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by frozen section. Pathology showed that the tumor was a
basal cell carcinoma. A margin free of tumor cells was
obtained and a reversed Hughes procedure was performed
[8]. The result was satisfactory and no recurrence was noted
during follow-up of 22 months.
DISCUSSION
In this series, more than 10% of eyelid tumors undergoing
resection were shown to be malignant by histopathologic
examination. This incidence is very high, but this series is
from a referral center where tumors are usually scheduled
for removal under suspicion of malignancy. However, the
high proportion should serve as an alert to primary care
physicians that timely referral is essential.
Nearly three-quarters of malignant eyelid tumors in this
series were basal cell carcinomas, which is similar to the
proportion of skin tumors and eyelid tumors in other series
[1,2,9–15]. Basal cell carcinoma, though malignant, has a
good prognosis if removed completely [16–18]. As a result,
early detection and referral for complete removal are
important. In this series, all tumors thought to be malignant
were removed with margin monitoring using frozen section.
No recurrence was noted, although follow-up times were
not long enough in some cases. Morpheaform basal cell
carcinoma usually presents with an indistinct tumor margin
(Case 6) [18]. The resection margin must be carefully
monitored by frozen section.
The second most common malignant tumor in this
series was sebaceous carcinoma, followed by squamous cell
carcinoma. Although this series was small, the order of
frequency was compatible with those of other Oriental
series [19–22]. In Oriental series, sebaceous carcinoma is
usually the second most common malignant tumor and
squamous cell carcinoma is the third, but in Western series,
squamous cell carcinoma is the second most common while
melanoma or sebaceous carcinoma is the third [9–15].
In a study to test the accuracy of clinical diagnosis,
agreement with final pathologic diagnosis was 84%
while about 5% of clinical diagnoses that were presumed to
be benign proved to be malignant [23]. In this study, four
malignant tumors were misdiagnosed before surgery.
However, two were thought to be other malignant tumors and
were resected with margin monitoring using frozen section.
The tumors were completely removed in the primary operation.
Two of 18 (> 10%) malignant tumors were misdiagnosed as
benign before surgery. Therefore, it is mandatory to submit all
tumor samples for pathologic examination.
Another interesting point to note of the malignant eyelid
tumors in this series was the predilection for lower eyelids
and female patients. Of basal cell carcinomas, 93% were
located in the lower eyelids and 71% were in female patients.
Further studies could focus on the hormonal effect, sunlight
exposure, and histologic differences between the upper and
lower eyelids.
In conclusion, malignancy can comprise up to 10% of
eyelid tumors that undergo surgery. On some occasions,
malignancies can be misdiagnosed. Therefore, the resection
specimen from eyelid tumors should always be submitted
for histopathologic examination.
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